Trial record 1 of 1 for:
nct03502668
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03502668 |
|
Recruitment Status :
Recruiting
First Posted : April 19, 2018
Last Update Posted : November 25, 2020
|
Sponsor:
Astex Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Astex Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2020 |
| Estimated Study Completion Date : | December 2020 |